Plato Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.71M Hold
9,440
– – 0.27% 82
2026
Q1
$4.64M Sell
9,440
-55
-0.6% -$29.8K 0.31% 72
2025
Q4
$5.53M Sell
9,495
-239
-2% -$135K 0.36% 64
2025
Q3
$4.69M Hold
9,734
– – 0.32% 70
2025
Q2
$3.93M Buy
9,734
+968
+11% +$405K 0.3% 78
2025
Q1
$4.41M Buy
8,766
+36
+0.4% +$19.5K 0.37% 62
2024
Q4
$4.56M Buy
8,730
+1,183
+16% +$650K 0.34% 65
2024
Q3
$4.66M Buy
7,547
+523
+7% +$310K 0.38% 55
2024
Q2
$3.88M Buy
7,024
+296
+4% +$170K 0.36% 64
2024
Q1
$3.91M Buy
6,728
+6,114
+996% +$3.43M 0.4% 61
2023
Q4
$326K Buy
+614
New +$297K 0.4% 60

Other funds holding TMO

Plato Investment Management's TMO Position: Q2 2026 in Review

Plato Investment Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 9,440 shares worth $4.71M. The position accounts for 0.27% of the portfolio, ranked #82.

Plato Investment Management first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.53M in Q4 2025. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Plato Investment Management held 9,440 shares of Thermo Fisher Scientific worth $4.71M as of Q2 2026.
  • Plato Investment Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.27% of Plato Investment Management's portfolio in Q2 2026, its #82 holding.
  • Plato Investment Management first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • Plato Investment Management's Thermo Fisher Scientific position peaked at $5.53M in Q4 2025.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Plato Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.